Formutech
event information
1 Conference | 20+ Speakers | 80+ Industry Leaders
mRNA Process Development
& Manufacturing |
LNP Formulations
FORMUTECH
The FormuTech Summit returns in 2027, bringing the international mRNA and LNP community to Maastricht, the Netherlands, for two days of scientific exchange, industry collaboration, and networking.
Building on previous editions, FormuTech continues to connect scientists, technology developers, pharmaceutical manufacturers, and regulatory experts working to advance RNA-based medicines. From early-stage research to clinical development and commercial manufacturing, the summit explores the technologies, processes, and partnerships needed to bring innovative RNA therapeutics closer to patients.
As the RNA therapeutics landscape expands beyond conventional mRNA vaccines, new opportunities and challenges are emerging in RNA engineering, lipid nanoparticle delivery, process development, analytical characterization, and manufacturing. FormuTech 2027 will explore these developments, with particular attention to improving product quality, manufacturing efficiency, scalability, and the translation of promising technologies into therapeutic applications.
The 2027 scientific programme will combine industry-led presentations, technical case studies, expert panel discussions, and interactive networking opportunities. Key topics will include next-generation RNA platforms, LNP formulation and delivery, IVT process optimization, advanced analytical technologies, automation, AI-driven development, and evolving regulatory expectations.
Hosted in Maastricht, at the heart of a highly connected European life sciences region, FormuTech 2027 offers an opportunity to exchange practical knowledge, establish new collaborations, and engage with the people and technologies shaping the future of RNA medicines.
Join us in Maastricht for the next edition of FormuTech Summit — where RNA innovation meets practical development and manufacturing.
What you will get
01
02
03
04
learn
The key practical points 2027
Next-Generation LNP Formulation & Delivery Technologies
Explore advances in lipid nanoparticle engineering, novel lipid systems, formulation optimization, and targeted delivery strategies to improve the performance of RNA-based therapeutics.
Advanced Analytical Technologies for RNA & LNP Characterization
Discover innovative methods for assessing RNA integrity, particle size, structural heterogeneity, purity, and stability, including chromatography, mass spectrometry, spectroscopy, and emerging analytical platforms.
RNA Engineering, Synthetic Biology & Emerging Therapeutic Platforms
Examine advances in RNA design, alternative RNA formats, synthetic biology, and programmable RNA technologies opening new possibilities for therapeutic development.
IVT Process Optimization & RNA Quality
Learn about improvements in in vitro transcription, enzymatic capping, DNA templates, dsRNA reduction, and process monitoring to support efficient production of high-quality RNA.
AI, Digitalization & Automated Development
Understand how artificial intelligence, predictive modelling, automated formulation screening, and digital tools are improving RNA development workflows and accelerating process optimization.
Scalable & Flexible RNA Manufacturing
Explore innovative manufacturing platforms, modular production systems, and process strategies designed to improve scalability, reproducibility, and cost efficiency from development to GMP manufacturing.
RNA-LNP Stability, Storage & Formulation Robustness
Examine approaches to improving RNA-LNP stability, including freeze-drying, formulation robustness, storage conditions, and technologies supporting broader distribution of RNA medicines.
Regulatory Science, Quality Control & CMC Strategies
Gain insight into regulatory expectations, analytical control strategies, manufacturing consistency, and CMC considerations for emerging RNA therapeutics and personalized medicines.
Targeted RNA Delivery & Expanding Therapeutic Applications
Discover advances in non-viral delivery, tissue-specific targeting, and alternative administration routes, including opportunities for RNA therapies beyond traditional vaccine applications.
Clinical Translation, Commercialization & Investment in RNA Therapeutics
Explore the scientific, manufacturing, and commercial considerations influencing the development of RNA medicines, from early therapeutic concepts to clinical translation, investment decisions, and market adoption.
what
you’ll discover at conference
Over 20+ Sessions , several networking opportunities in a special venue chosen by our team makes this event unique and unforgettable
who
Should attend
Members of board, C-level, Senior Vice Presidents, Vice Presidents, Directors and Heads of departments of:
- Analytics
- Analytical Science
- Bioprocessing
- Cancer Immunotherapy
- Clinical Development
- Chemistry, Manufacturing, and Control (CMC)
- Commercialisation
- Comparability
- Good Manufacturing Practices (GMP)
- Drug Product Development
- Drug Substance
- Impurities
- Innovation Chemistry
- In-Vitro Transcription
- Formulation
- Lipid Nanoparticles (LNP)
- Manufacturing, Science &
- Technologies (MSAT)
- Messenger RNA (mRNA)
- mRNA-Based Therapies
- Oncology
- Plasmid DNA (pDNA)
- Process Analytical Technology (PAT)
- Product Characterisation
- Process Development
- Production Engineering
- Purification
- Ribonucleic Acid (RNA)
- RNA Therapeutics
- Quality Assurance (QA)
- Quality by Design (QbD)
- Quality Control (QC)
- Research and Development (R&D)
- Regulatory
- Safety
- Scale Up
- Supply Chain
- Vaccines
register now
FormuTech 2027
October, 2027 | Maastricht, Netherlands
Industry Package
995€
- 2-Days Full Access
- Coffee-Breaks & Lunch
- Doc. Package
- e-Poster Submission
mRNA Process Development & Manufacturing | LNP Formulations
© 2017 Copyright All Rights Reserved | Powered by EPM Group